ArticleCancers2022

Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser.

Silje Haukali Omland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.